Professionals 376 results
Capabilities 78 results
Practice Area
Government Program Fraud, False Claims Act & Qui Tam Litigation
Industry
Practice Area
Environmental Litigation & Enforcement
Experience 52 results
Experience
|June 11, 2024
Granite Construction Incorporated Closes $373.75M Offering of Convertible Senior Notes
Experience
|January 24, 2024
Winston Represents Grupo Calleja in its US$1.2 billion Acquisition of Almacenes Éxito
Insights & News 3,007 results
Benefits Blast
|July 3, 2024
|3 Min Read
Last month, the United States (U.S.) Court of Appeals for the Fifth Circuit partially upheld a lower court ruling in Braidwood Management Inc. v. Becerra that invalidated the preventive care mandate under the Affordable Care Act (ACA).
Capital Markets & Securities Law Watch
|July 2, 2024
|3 Min Read
Large Accelerated Filers Must Tag Fee Exhibits in XBRL Starting July 31, 2024
On October 31, 2021, the Securities and Exchange Commission (SEC) adopted final rules modifying the requirements applicable to filing fee disclosure and payment methods for several fee-bearing forms, schedules, statements and related rules.
Client Alert
|July 1, 2024
|8 Min Read
The Supreme Court announced a major restriction on a common practice for Chapter 11 bankruptcy reorganization plans, sending a multi-billion-dollar settlement involving the Purdue Pharma opioid litigation back to the drawing board. In Harrington v. Purdue Pharma L.P., the high court held that the bankruptcy court could not enter a release benefitting the Sackler family, who were accused of funneling $11 billion from the now-bankrupt Purdue Pharma but had not themselves filed bankruptcy petitions. The plan would have released the Sacklers in exchange for contributing up to $6 billion to pay opioid-related claims against them and Purdue Pharma in connection with OxyContin addiction.
Other Results 88 results
Site Content
Law Glossary
What Is the Securities Act of 1933?
Law Glossary